Newborn Screening: the road to 2024

As we look forward to 2024, our Senior Account Executive, Robbie Lockyer, considers the outlook for newborn screening for rare diseases, and discusses whether the UK is will continue to fall behind our European neighbours. Since the 1950s, when the newborn blood spot (NBS) screening programme was first introduced (commonly referred to as the heel prick …